Kala Pharmaceuticals (KALA) Reports In-Line Q1 EPS, Revenues Beat

Go back to Kala Pharmaceuticals (KALA) Reports In-Line Q1 EPS, Revenues Beat
(NASDAQ: KALA) Delayed: 0.88 --0 (-0%)
Previous Close $0.88    52 Week High
Open $0.88    52 Week Low
Day High $0.88    P/E N/A 
Day Low $0.88    EPS
Volume 647